The TRAPIST Study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound

Authors:
  • DFD.P. Foley
    D.P. Foley
  • MPM. Pieper
    M. Pieper
  • JKJ.A. Kleijne
    J.A. Kleijne
Open Access
Publisher website
Google Scholar
Abstract
Background Studies have reported benefit of oral therapy with the phosphodiesterase inhibitor, trapidil, in reducing restenosis after coronary angiop